QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 novabay-pharmaceuticals-q2-eps-137-misses-123-estimate-sales-240m-miss-315m-estimate

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate o...

 whats-going-on-with-novabay-pharmaceuticals-nby-stock

NovaBay Pharmaceuticals shares are lower by 66% over the trailing five sessions. The company last week announced the pricing of...

 why-novabay-pharmaceuticals-nby-stock-is-down-60

NovaBay Pharmaceuticals shares are trading lower by 61% during Friday's session. The company announced the pricing of its p...

 novabay-pharmaceuticals-announces-preliminary-net-revenue-for-the-second-quarter-of-2024-of-24m-versus-consensus-of-315m-and-for-the-first-half-of-2024-of-5m-primarily-derived-from-the-companys-eyecare-products

Net revenue from the Company's eyecare products increased by 9% for both the second quarter and the first half of 2024 over...

Core News & Articles

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a company developing and commercializing high-quality eyecare products, and Eyenovia...

 novabay-pharmaceuticals-plans-1-for-35-reverse-stock-split-and-reveals-receipt-of-nyse-american-notice-regarding-stockholders-equity

The Company anticipates that the 1-for-35 reverse stock split will be effective as of 4:15 p.m. New York City time on Thursday,...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION